JP2021506907A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021506907A5 JP2021506907A5 JP2020534340A JP2020534340A JP2021506907A5 JP 2021506907 A5 JP2021506907 A5 JP 2021506907A5 JP 2020534340 A JP2020534340 A JP 2020534340A JP 2020534340 A JP2020534340 A JP 2020534340A JP 2021506907 A5 JP2021506907 A5 JP 2021506907A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- composition according
- renal dysfunction
- pema
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- ZHKNLJLMDFQVHJ-RUZDIDTESA-N (2r)-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid Chemical compound CC[C@H](C(O)=O)OC1=CC=CC(CN(CCCOC=2C=CC(OC)=CC=2)C=2OC3=CC=CC=C3N=2)=C1 ZHKNLJLMDFQVHJ-RUZDIDTESA-N 0.000 claims 5
- 229950009401 pemafibrate Drugs 0.000 claims 5
- 230000008085 renal dysfunction Effects 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 3
- 108010023302 HDL Cholesterol Proteins 0.000 claims 2
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 2
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 claims 1
- 108010028554 LDL Cholesterol Proteins 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- 206010062237 Renal impairment Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023187862A JP2023181451A (ja) | 2017-12-21 | 2023-11-01 | 高トリグリセライド血症の治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762609048P | 2017-12-21 | 2017-12-21 | |
| US62/609,048 | 2017-12-21 | ||
| PCT/US2018/066976 WO2019126597A1 (en) | 2017-12-21 | 2018-12-20 | Methods of treatment of hypertrigl yceridemia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023187862A Division JP2023181451A (ja) | 2017-12-21 | 2023-11-01 | 高トリグリセライド血症の治療方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021506907A JP2021506907A (ja) | 2021-02-22 |
| JP2021506907A5 true JP2021506907A5 (enExample) | 2022-01-11 |
Family
ID=66995099
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020534340A Pending JP2021506907A (ja) | 2017-12-21 | 2018-12-20 | 高トリグリセライド血症の治療方法 |
| JP2023187862A Pending JP2023181451A (ja) | 2017-12-21 | 2023-11-01 | 高トリグリセライド血症の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023187862A Pending JP2023181451A (ja) | 2017-12-21 | 2023-11-01 | 高トリグリセライド血症の治療方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20190224169A1 (enExample) |
| EP (1) | EP3727376A4 (enExample) |
| JP (2) | JP2021506907A (enExample) |
| CN (1) | CN111741753A (enExample) |
| AU (1) | AU2018393119B2 (enExample) |
| CA (1) | CA3085951C (enExample) |
| MY (1) | MY205171A (enExample) |
| SG (1) | SG11202005850VA (enExample) |
| WO (1) | WO2019126597A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119546300A (zh) * | 2022-07-15 | 2025-02-28 | 兴和株式会社 | 血中ldl胆固醇降低剂 |
| WO2024167964A1 (en) * | 2023-02-08 | 2024-08-15 | Kowa Company, Ltd. | Methods of treating and preventing peripheral artery disease |
| WO2025069226A1 (ja) * | 2023-09-26 | 2025-04-03 | 興和株式会社 | ペマフィブラートを含有する医薬 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004270538C1 (en) * | 2003-09-03 | 2010-01-14 | Kowa Co., Ltd | PPAR-activating compound and pharmaceutical composition containing same |
| TWI407955B (zh) | 2007-03-29 | 2013-09-11 | Kowa Co | 高脂血症之預防及／或治療劑 |
| EA024873B1 (ru) * | 2012-09-27 | 2016-10-31 | Кова Компани, Лтд. | Терапевтическое средство при дислипидемии |
| CN106470675A (zh) * | 2014-06-26 | 2017-03-01 | 西玛贝医药公司 | 严重高甘油三酯血症的治疗 |
| TWI691331B (zh) * | 2014-09-26 | 2020-04-21 | 日商興和股份有限公司 | 脂質異常症治療劑 |
| ES2847168T5 (es) | 2016-07-29 | 2024-02-20 | Kowa Co | Métodos para prevenir acontecimientos cardiovasculares en poblaciones dislipidémicas de riesgo residual |
-
2018
- 2018-12-20 CA CA3085951A patent/CA3085951C/en active Active
- 2018-12-20 WO PCT/US2018/066976 patent/WO2019126597A1/en not_active Ceased
- 2018-12-20 MY MYPI2020003113A patent/MY205171A/en unknown
- 2018-12-20 CN CN201880089648.7A patent/CN111741753A/zh active Pending
- 2018-12-20 EP EP18892061.5A patent/EP3727376A4/en active Pending
- 2018-12-20 JP JP2020534340A patent/JP2021506907A/ja active Pending
- 2018-12-20 SG SG11202005850VA patent/SG11202005850VA/en unknown
- 2018-12-20 US US16/227,440 patent/US20190224169A1/en not_active Abandoned
- 2018-12-20 AU AU2018393119A patent/AU2018393119B2/en active Active
-
2023
- 2023-11-01 JP JP2023187862A patent/JP2023181451A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100296954B1 (ko) | 신규의항알러지항염증조성물 | |
| CA2393437A1 (en) | Exo-s-mecamylamine formulation and use in treatment | |
| JP2018507243A5 (enExample) | ||
| JP2021152008A5 (enExample) | ||
| JP2013541583A5 (enExample) | ||
| JP2021506907A5 (enExample) | ||
| JP2018516266A5 (enExample) | ||
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| KR102055859B1 (ko) | 아캄프로세이트 제제, 그것의 사용 방법, 및 그것을 포함하는 조합 | |
| JP2022525202A (ja) | 肺動脈性肺高血圧症および各種疾患に伴う肺動脈性肺高血圧症の治療法と１日あたりの投薬量 | |
| WO2009123206A1 (ja) | 経口医薬組成物 | |
| AU2016353350A1 (en) | Formulation of L-ornithine phenylacetate | |
| JP6642892B2 (ja) | ジメチルアミノミケリオリドを含む肺線維化の治療薬 | |
| KR20120089623A (ko) | 정맥내 투여용 이부프로펜을 이용한 환자의 치료 | |
| MX2022012693A (es) | Composicion que comprende metilfolato. | |
| RU2019102890A (ru) | Фармацевтические композиции, содержащие флурбипрофен | |
| JP6100510B2 (ja) | 抗感冒剤 | |
| CA2469702A1 (en) | Darifenacin for use in the treatment of urgency induced by overactive bladder | |
| US20130142869A1 (en) | Compositions Comprising Non Steroidal Anti-inflammatory Drugs and Methods for Use Thereof | |
| JP2007137896A (ja) | イブプロフェン含有医薬製剤 | |
| JPWO2021170793A5 (enExample) | ||
| RU2025138567A (ru) | Химические соединения и их применение | |
| JP6047004B2 (ja) | 安全な医薬組成物 | |
| RU2025132881A (ru) | Лечение псориаза с применением низкомолекулярного ингибитора фактора некроза опухоли альфа | |
| RU2018119120A (ru) | D-пролиновые производные в качестве агента, уменьшающего количество sap |